Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 360

1.

Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo.

Beaulieu JM, Tirotta E, Sotnikova TD, Masri B, Salahpour A, Gainetdinov RR, Borrelli E, Caron MG.

J Neurosci. 2007 Jan 24;27(4):881-5.

2.

Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists.

Caine SB, Negus SS, Mello NK, Patel S, Bristow L, Kulagowski J, Vallone D, Saiardi A, Borrelli E.

J Neurosci. 2002 Apr 1;22(7):2977-88.

3.
4.

The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice.

Ralph RJ, Varty GB, Kelly MA, Wang YM, Caron MG, Rubinstein M, Grandy DK, Low MJ, Geyer MA.

J Neurosci. 1999 Jun 1;19(11):4627-33.

6.
7.

Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.

Depoortère R, Bardin L, Rodrigues M, Abrial E, Aliaga M, Newman-Tancredi A.

Behav Pharmacol. 2009 Jul;20(4):303-11. doi: 10.1097/FBP.0b013e32832ec5aa.

PMID:
19584712
8.

Dopamine D4 receptor-induced postsynaptic inhibition of GABAergic currents in mouse globus pallidus neurons.

Shin RM, Masuda M, Miura M, Sano H, Shirasawa T, Song WJ, Kobayashi K, Aosaki T.

J Neurosci. 2003 Dec 17;23(37):11662-72.

9.

Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses.

Zapata A, Witkin JM, Shippenberg TS.

Neuropharmacology. 2001 Sep;41(3):351-9.

PMID:
11522326
10.

Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors.

Zhang L, Lou D, Jiao H, Zhang D, Wang X, Xia Y, Zhang J, Xu M.

J Neurosci. 2004 Mar 31;24(13):3344-54.

11.

Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.

Grundt P, Carlson EE, Cao J, Bennett CJ, McElveen E, Taylor M, Luedtke RR, Newman AH.

J Med Chem. 2005 Feb 10;48(3):839-48.

PMID:
15689168
12.

S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo.

Millan MJ, Svenningsson P, Ashby CR Jr, Hill M, Egeland M, Dekeyne A, Brocco M, Di Cara B, Lejeune F, Thomasson N, Munoz C, Mocaër E, Crossman A, Cistarelli L, Girardon S, Iob L, Veiga S, Gobert A.

J Pharmacol Exp Ther. 2008 Feb;324(2):600-11. Epub 2007 Nov 16.

13.
14.

The discovery of PD 89211 and related compounds: selective dopamine D4 receptor antagonists.

Pugsley TA, Shih YH, Whetzel SZ, Zoski K, Van Leeuwen D, Akunne H, Mackenzie R, Heffner TG, Wustrow D, Wise LD.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Feb;26(2):219-26.

PMID:
11817497
15.

Dopamine modulates von Willebrand factor secretion in endothelial cells via D2-D4 receptors.

Zarei S, Frieden M, Rubi B, Villemin P, Gauthier BR, Maechler P, Vischer UM.

J Thromb Haemost. 2006 Jul;4(7):1588-95.

17.

Dopamine D3 and D4 receptor antagonists: synthesis and structure--activity relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl) amino]-2-methoxybenzamide (YM-43611) and related compounds.

Ohmori J, Maeno K, Hidaka K, Nakato K, Matsumoto M, Tada S, Hattori H, Sakamoto S, Tsukamoto S, Usuda S, Mase T.

J Med Chem. 1996 Jul 5;39(14):2764-72.

PMID:
8709107
18.

Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.

Flores-Tochihuitl J, Vargas G, Morales-Medina JC, Rivera G, De La Cruz F, Zamudio S, Flores G.

Synapse. 2008 Jan;62(1):40-9.

PMID:
17957737
19.

D2-like dopamine receptors modulate SKCa channel function in subthalamic nucleus neurons through inhibition of Cav2.2 channels.

Ramanathan S, Tkatch T, Atherton JF, Wilson CJ, Bevan MD.

J Neurophysiol. 2008 Feb;99(2):442-59. Epub 2007 Dec 19.

PMID:
18094105
20.

The expression of neuropeptide-induced excessive grooming behavior in dopamine D1 and D2 receptor-deficient mice.

Drago F, Contarino A, Busà L.

Eur J Pharmacol. 1999 Jan 22;365(2-3):125-31.

PMID:
9988094

Supplemental Content

Support Center